Moussa C, Pagan F, Hebron M et al. Nilotinib is a Multi Kinase Inhibitor that Alters Cerebrospinal Fluid (CSF) Biomarkers and Increases TREM2 Levels in Individuals with Parkinson Disease. AAN 2019, S10.007.
Extra voordeel langere dosisinterval natalizumab: minder JCV-conversie
mei 2025 | Multipele Sclerose